Alto Neuroscience Promotes Nick Smith To President, CFO, Effective Aug. 26
Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company developing novel precision medicines for neuropsychiatric disorders, today announced the promotion of Nick Smith to president and chief
Alto Neuroscience moved Nick Smith into a bigger leadership job starting August 26. When companies promote people to top positions, it shows the company is planning ahead and believes in that person's ability to help it grow.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.